Nabeel Ahmed - Jan 17, 2025 Form 4 Insider Report for Outset Medical, Inc. (OM)

Signature
By: John L Brottem For: Nabeel Ahmed
Stock symbol
OM
Transactions as of
Jan 17, 2025
Transactions value $
-$27,430
Form type
4
Date filed
1/22/2025, 06:02 PM
Previous filing
Jan 13, 2025
Next filing
Feb 19, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Award $0 +13.3K +4.74% $0.00 293K Jan 17, 2025 Direct F1
transaction OM Common Stock Sale -$726 -907 -0.31% $0.80 292K Jan 21, 2025 Direct F2
transaction OM Common Stock Sale -$23.6K -29.5K -10.09% $0.80 263K Jan 21, 2025 Direct F3
transaction OM Common Stock Sale -$3.13K -3.91K -1.49% $0.80 259K Jan 21, 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 6, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024. The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive a share of common stock. These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period.
F2 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 1,538 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on January 26, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F3 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 50,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F4 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.